• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

川崎病的病毒合并感染:一项荟萃分析。

Viral Coinfections in Kawasaki Disease: A Meta-analysis.

机构信息

Department of Pediatrics, Children's Hospital Colorado and University of Colorado School of Medicine, Aurora, Colorado.

Divisions of Pediatric Hospital Medicine.

出版信息

Hosp Pediatr. 2023 Jun 1;13(6):e153-e169. doi: 10.1542/hpeds.2023-007150.

DOI:10.1542/hpeds.2023-007150
PMID:37170763
Abstract

CONTEXT

Viral infections are suspected triggers in Kawasaki disease (KD); however, a specific viral trigger has not been identified.

OBJECTIVES

In children with KD, to identify (1) overall prevalence of viral infections; (2) prevalence of specific viruses; and (3) whether viral positivity was associated with coronary artery aneurysms (CAAs) or refractoriness to intravenous immunoglobin (IVIG).

DATA SOURCES

We searched Embase, Medline, and Cochrane databases and gray literature.

STUDY SELECTION

Eligible studies were conducted between 1999 and 2019, and included children diagnosed with KD who underwent viral testing.

DATA EXTRACTION

Two investigators independently reviewed full-text articles to confirm eligibility, extract data, appraise for bias, and assess evidence quality for outcomes using the Grading of Recommendations Assessment Development and Evaluation criteria. We defined viral positivity as number of children with a positive viral test divided by total tested. Secondary outcomes were CAA (z score ≥2.5) and IVIG refractoriness (fever ≥36 hours after IVIG).

RESULTS

Of 3189 unique articles identified, 54 full-text articles were reviewed, and 18 observational studies were included. Viral positivity weighted mean prevalence was 30% (95% confidence interval [CI], 14-51) and varied from 5% to 66%, with significant between-study heterogeneity. Individual virus positivity was highest for rhinovirus (19%), adenovirus (10%), and coronavirus (7%). Odds of CAA (odds ratio, 1.08; 95% CI, 0.75-1.56) or IVIG refractoriness (odds ratio, 0.88; 95% CI, 0.58-1.35) did not differ on the basis of viral status.

LIMITATIONS

Low or very low evidence quality.

CONCLUSIONS

Viral infection was common with KD but without a predominant virus. Viral positivity was not associated with CAAs or IVIG refractoriness.

摘要

背景

病毒感染被怀疑是川崎病(KD)的触发因素;然而,尚未确定特定的病毒触发因素。

目的

在 KD 患儿中,确定(1)病毒感染的总体患病率;(2)特定病毒的患病率;以及(3)病毒阳性是否与冠状动脉瘤(CAA)或静脉注射免疫球蛋白(IVIG)抵抗有关。

数据来源

我们检索了 Embase、Medline 和 Cochrane 数据库以及灰色文献。

研究选择

合格的研究于 1999 年至 2019 年进行,纳入接受病毒检测的确诊为 KD 的儿童。

数据提取

两名研究者独立审查全文文章以确认合格性、提取数据、评估偏倚,并使用推荐评估、制定与评估分级标准评估结局的证据质量。我们将病毒阳性定义为阳性病毒检测的儿童数量除以总检测数。次要结局为 CAA(z 评分≥2.5)和 IVIG 抵抗(IVIG 后 36 小时仍发热)。

结果

在 3189 篇独特的文章中,有 54 篇全文文章被审查,18 项观察性研究被纳入。病毒阳性的加权平均患病率为 30%(95%置信区间,14-51),范围从 5%到 66%,存在显著的研究间异质性。鼻病毒(19%)、腺病毒(10%)和冠状病毒(7%)的阳性率最高。CAA(比值比,1.08;95%置信区间,0.75-1.56)或 IVIG 抵抗(比值比,0.88;95%置信区间,0.58-1.35)的病毒状态无差异。

局限性

低或极低的证据质量。

结论

病毒感染在 KD 中很常见,但没有一种主要的病毒。病毒阳性与 CAA 或 IVIG 抵抗无关。

相似文献

1
Viral Coinfections in Kawasaki Disease: A Meta-analysis.川崎病的病毒合并感染:一项荟萃分析。
Hosp Pediatr. 2023 Jun 1;13(6):e153-e169. doi: 10.1542/hpeds.2023-007150.
2
Intravenous immunoglobulin for the treatment of Kawasaki disease.静脉注射免疫球蛋白治疗川崎病。
Cochrane Database Syst Rev. 2023 Jan 25;1(1):CD014884. doi: 10.1002/14651858.CD014884.pub2.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Analysis of Age, Sex, Lack of Response to Intravenous Immunoglobulin, and Development of Coronary Artery Abnormalities in Children With Kawasaki Disease in Japan.日本川崎病患儿的年龄、性别、静脉注射免疫球蛋白无反应和冠状动脉异常分析。
JAMA Netw Open. 2022 Jun 1;5(6):e2216642. doi: 10.1001/jamanetworkopen.2022.16642.
5
Risk Factors for Coronary Artery Aneurysm in a Chinese Pediatric Population with Kawasaki Disease at Low Risk of Intravenous Immunoglobulin Resistance: A Retrospective Cohort Study.冠状动脉瘤风险因素:中国低丙种球蛋白血症型川崎病患儿的回顾性队列研究
Cardiology. 2023;148(5):457-468. doi: 10.1159/000530708. Epub 2023 May 23.
6
TNF-α blockers for the treatment of Kawasaki disease in children.用于治疗儿童川崎病的肿瘤坏死因子-α阻滞剂。
Cochrane Database Syst Rev. 2019 Aug 16;8(8):CD012448. doi: 10.1002/14651858.CD012448.pub2.
7
Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol.多中心、随机、开放标签、盲终点评估的皮质类固醇加静脉注射免疫球蛋白(IVIG)和阿司匹林与 IVIG 和阿司匹林预防川崎病(KD)冠状动脉瘤(CAA)的试验:KD CAA 预防(KD-CAAP)试验方案。
Trials. 2023 Jan 26;24(1):60. doi: 10.1186/s13063-022-07051-9.
8
Correlation of Coronary Artery Abnormalities with Fever Pattern in Patients with Kawasaki Disease.川崎病患者冠状动脉异常与发热模式的相关性。
J Pediatr. 2021 Sep;236:95-100. doi: 10.1016/j.jpeds.2021.05.020. Epub 2021 May 19.
9
Delayed Development of Coronary Artery Aneurysm in Patients with Kawasaki Disease Who Were Clinically Responsive to Immunoglobulin.对免疫球蛋白临床反应良好的川崎病患者冠状动脉瘤的延迟发生
J Pediatr. 2020 Dec;227:224-230.e3. doi: 10.1016/j.jpeds.2020.08.032. Epub 2020 Aug 15.
10
Patterns of Fever in Children After Primary Treatment for Kawasaki Disease.川崎病初次治疗后儿童的发热模式
Pediatr Infect Dis J. 2015 Dec;34(12):1315-8. doi: 10.1097/INF.0000000000000891.

引用本文的文献

1
A new scoring in differential diagnosis: multisystem inflammatory syndrome or adenovirus infection?鉴别诊断中的一种新评分:多系统炎症综合征还是腺病毒感染?
Turk J Med Sci. 2024 Oct 6;54(6):1237-1243. doi: 10.55730/1300-0144.5905. eCollection 2024.
2
Possible Involvement of Infection with Human Rhinoviruses in Children with Kawasaki Disease.人鼻病毒感染与川崎病患儿的可能关联。
Mediterr J Hematol Infect Dis. 2023 Sep 1;15(1):e2023049. doi: 10.4084/MJHID.2023.049. eCollection 2023.